3GU-17567-20186
3 vaccinations
5 coded responses
39 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 532 / WI
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-26
- 2021-04-01
- 2021-04-08
-
2021-04-09
Dose 2 — Pfizer-BioNTech
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
-
2021-07-09
Survey response — 3 months, dose 2MedDRA: Cough, Nasal congestion, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Nasal congestion, cough, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-08
Survey response — 6 months, dose 2MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Be unable to work or attend schoolFree text: Cough, sore throat, congestion for 4 weeksMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Dose 3 — Pfizer-BioNTech
- 2021-10-12
-
2021-10-13
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-15
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-21
-
2021-10-26
Survey response — day 14, dose 3MedDRA: Nasal congestion, Throat irritation — Feeling: Good · Be unable to work or attend schoolFree text: Slight stuffy nose, irritated throatMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2022-01-11
-
2022-04-12
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Cold symptoms 2 separate timesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: Good · Be unable to work or attend schoolFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
Free text
Release 9 — 3 months, dose 2
Symptoms: Nasal congestion, cough, sore throat
Release 10 — 6 months, dose 2
Symptoms: Cough, sore throat, congestion for 4 weeks
Release 10 — day 14, dose 3
Symptoms: Slight stuffy nose, irritated throat
Release 11 — 6 months, dose 3
Symptoms: Cold symptoms 2 separate times
Release 12 — 12 months, dose 3
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release